Vertex Pharmaceuticals Incorporated Cash Conversion Cycle 2011-2025 | VRTX

Annual Cash Conversion Cycle Vertex Pharmaceuticals Incorporated

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
192	132	106	106	95.6	109	69	107	71.8	14.9	-185	-72.8	-58.1	219

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
219	-185	64.7

Quarterly Cash Conversion Cycle Vertex Pharmaceuticals Incorporated

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
306	278	271	-	204	188	168	-	136	124	120	-	68.3	55.7	113	-	124	122	120	106	114	115	103	80.3	116	115	100	52.9	58.6	61.4	81.8	80.5	91.8	95.7	83.2	39.9	44.3	42.5	43	38	51.8	97.6	83.5	48	38.7	50.1	62.2	22.2	35.2	25.1	31.8	39.1	38.9	31.2	33.9	29.7	25.4	146	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
306	22.2	91.7

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.79	2.35 %	$ 795 M	Canada
Aclaris Therapeutics ACRS	-881	$ 3.04	4.83 %	$ 235 M	USA
Aptevo Therapeutics APVO	-47.4	$ 0.93	-8.81 %	$ 257 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Catalyst Biosciences CBIO	391	$ 12.37	2.06 %	$ 814 M	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.81	1.36 %	$ 1.3 B	USA
Anika Therapeutics ANIK	270	$ 9.48	0.96 %	$ 139 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 591.15	0.02 %	$ 44.8 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.53	-0.39 %	$ 15.9 M	USA
AstraZeneca PLC AZN	-58	$ 92.45	0.34 %	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 26.83	0.94 %	$ 1.73 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 10.81	2.95 %	$ 699 M	USA
Biogen BIIB	387	$ 176.33	0.86 %	$ 25.7 B	USA
Abeona Therapeutics ABEO	387	$ 5.41	2.08 %	$ 116 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 83.59	1.95 %	$ 8.63 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.45	0.91 %	$ 2.9 B	USA
CorMedix CRMD	-215 K	$ 12.19	1.75 %	$ 621 M	USA
ADiTx Therapeutics ADTX	-4.31 K	$ 1.14	-9.52 %	$ 15 K	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA